PRIMAL THERAPIES, INC. Trademark

Trademark Overview

On Monday, May 22, 2017, a trademark application was filed for PRIMAL THERAPIES, INC. with the United States Patent and Trademark Office. The USPTO has given the PRIMAL THERAPIES, INC. trademark a serial number of 87458992. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, June 14, 2024. This trademark is owned by Primal Therapies, Inc.. The PRIMAL THERAPIES, INC. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
primal therapies, inc.

General Information

Serial Number87458992
Word MarkPRIMAL THERAPIES, INC.
Filing DateMonday, May 22, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, June 14, 2024
Registration Number5359704
Registration DateTuesday, December 19, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 3, 2017

Trademark Statements

NOT AVAILABLE"THERAPIES, INC."
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 26, 2017
Primary Code042
First Use Anywhere DateSunday, April 1, 2012
First Use In Commerce DateSunday, April 1, 2012

Trademark Owner History

Party NamePrimal Therapies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMinneapolis, MN 55413
Party NamePrimal Therapies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoise, ID 83704
Party NamePrimal Therapies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoise, ID 83704

Trademark Events

Event DateEvent Description
Wednesday, September 13, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 25, 2017NEW APPLICATION ENTERED
Friday, May 26, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 21, 2017ASSIGNED TO EXAMINER
Tuesday, August 22, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 8, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 8, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 11, 2023TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 3, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 3, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, August 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 19, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 14, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, August 20, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, August 20, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 20, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 20, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 14, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, June 14, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Related Keywords

therapies primal pharmaceutical development research services pharmaceuticals trials scientific medical information field